The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2026 and 2025 (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Acadia Healthcare Company, Inc. |
|
$ |
10,928 |
|
|
$ |
30,127 |
|
|
$ |
15,033 |
|
|
$ |
38,501 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding for basic earnings per share |
|
|
90,817 |
|
|
|
90,328 |
|
|
|
90,675 |
|
|
|
90,987 |
|
Effects of dilutive instruments |
|
|
557 |
|
|
|
107 |
|
|
|
530 |
|
|
|
413 |
|
Shares used in computing diluted earnings per common share |
|
|
91,374 |
|
|
|
90,435 |
|
|
|
91,205 |
|
|
|
91,400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share attributable to Acadia Healthcare
Company, Inc. stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.12 |
|
|
$ |
0.33 |
|
|
$ |
0.17 |
|
|
$ |
0.42 |
|
Diluted |
|
$ |
0.12 |
|
|
$ |
0.33 |
|
|
$ |
0.16 |
|
|
$ |
0.42 |
|
|